Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Nitroglycerin is effective as sublingual medication because it is:

Nonionic and highly lipid soluble. **Explanation:** The effectiveness of sublingual Nitroglycerin (GTN) depends on the principles of **passive diffusion** across the oral mucosa. For a drug to be absorbed rapidly through the lipid bilayer of cell membranes, it must possess specific physicochemical properties. **1. Why Option C is Correct:** * **Nonionic (Uncharged) State:** According to the pH partition hypothesis, only the unionized form of a drug is lipid-soluble and capable of crossing biological membranes. Nitroglycerin exists primarily in a nonionic state at physiological pH. * **High Lipid Solubility:** The oral mucosa is a lipid-rich barrier. Nitroglycerin’s high lipid solubility (high oil/water partition coefficient) allows it to dissolve into the membrane and enter the systemic circulation rapidly, bypassing the first-pass metabolism in the liver. **2. Why Other Options are Incorrect:** * **Options A & B (Ionic):** Charged or ionized molecules are water-soluble (polar) but have poor lipid permeability. They cannot cross the cell membranes effectively, leading to poor and slow absorption. * **Option D (Less Lipid Soluble):** Even if a drug is nonionic, low lipid solubility would result in a slow rate of diffusion, making it unsuitable for the rapid relief required in acute angina. **High-Yield Clinical Pearls for NEET-PG:** * **First-Pass Metabolism:** Sublingual administration avoids the **extensive first-pass metabolism** (approx. 90%) that Nitroglycerin undergoes in the liver when taken orally. * **Onset of Action:** Sublingual GTN acts within 1–3 minutes. * **Storage:** GTN is volatile and sensitive to light/moisture; it should be stored in tightly closed, dark glass containers. * **Mechanism:** It acts by releasing Nitric Oxide (NO), which increases cGMP, leading to peripheral vasodilation (primarily venodilation) and reduced preload.

Q: Which of the following is the fastest acting receptor?

GABAa. **Explanation:** The speed of a receptor's response is determined by its mechanism of signal transduction. Receptors are generally classified into four types based on their signaling speed. **1. Why GABAa is Correct:** **GABAa** is a **Ligand-gated ion channel (Ionotropic receptor)**. These are the fastest-acting receptors because the receptor itself is an ion channel. Upon ligand binding, the channel undergoes an immediate conformational change, allowing ions (in this case, Chloride) to flow across the membrane. This process occurs within **milliseconds**, making it ideal for rapid synaptic transmission. **2. Why the other options are incorrect:** * **Beta1 and M2 (Options A & B):** These are **G-Protein Coupled Receptors (GPCRs/Metabotropic receptors)**. They act via second messengers (like cAMP or IP3/DAG). Because they require a cascade of intracellular signaling steps, their response time is slower, typically taking **seconds**. * **Estrogen receptor (Option D):** This is a **Nuclear/Intracellular receptor**. These receptors act by altering gene transcription and protein synthesis. This is a slow process, taking **hours to days** to manifest an effect. **3. High-Yield Clinical Pearls for NEET-PG:** * **Speed Hierarchy:** Ion Channels (msec) > GPCRs (sec) > Enzyme-linked (min/hrs) > Nuclear receptors (hrs/days). * **GABAa vs. GABAb:** Remember that GABAa is ionotropic (fast, Cl- channel), while GABAb is metabotropic (slow, GPCR). * **Fastest overall:** While GABAa is the fastest among the options, the **Nicotinic Acetylcholine Receptor (nAChR)** is often cited as the classic prototype for the fastest ligand-gated ion channel. * **Nuclear Receptors:** These are the only receptors that primarily function in the nucleus to regulate mRNA synthesis (e.g., Steroids, Thyroid hormone, Vitamin D).

Q: A young male presents with severe asthma. The pharmacokinetics of theophylline include the following parameters: Vd = 35 L; CL = 48 mL/min; half-life = 8 hours. If an intravenous infusion of theophylline is started at a rate of 0.48 mg/min, how long will it take to reach 93.75% of the steady state concentration?

Approximately 32 hours. **Explanation:** The core concept tested here is the **relationship between half-life ($t_{1/2}$) and the time required to reach steady-state concentration ($C_{ss}$)** during a continuous drug infusion. 1. **Why Option D is Correct:** In pharmacokinetics, the approach to steady state is a first-order process. It is a high-yield rule that the time taken to reach steady state depends **only on the half-life** of the drug, not on the dose or infusion rate. * After 1 $t_{1/2}$: 50% of $C_{ss}$ is reached. * After 2 $t_{1/2}$: 75% of $C_{ss}$ is reached. * After 3 $t_{1/2}$: 87.5% of $C_{ss}$ is reached. * **After 4 $t_{1/2}$: 93.75% of $C_{ss}$ is reached.** * After 5 $t_{1/2}$: 96.8% (~97%) of $C_{ss}$ is reached. Given the half-life ($t_{1/2}$) is **8 hours**, the time to reach 93.75% is $4 \times 8 \text{ hours} = \mathbf{32 \text{ hours}}$. 2. **Why Other Options are Incorrect:** * **Option A (48 mins):** This is a distractor using the Clearance (CL) value. * **Option B (5.8 hours):** This is a distractor using the $V_d$ or incorrect math. * **Option C (8 hours):** This represents only 1 half-life (50% of $C_{ss}$), which is insufficient. 3. **Clinical Pearls for NEET-PG:** * **Steady State:** It takes approximately **4 to 5 half-lives** to reach clinical steady state. * **Loading Dose:** If a rapid effect is needed (like in acute asthma), a **loading dose** ($LD = V_d \times \text{Target } C_p$) is given to bypass the delay in reaching steady state. * **Elimination:** Similarly, it takes 4–5 half-lives for a drug to be completely eliminated from the body after stopping the infusion. * **Theophylline:** It has a narrow therapeutic index; toxicity can occur if clearance is decreased (e.g., by Cimetidine or Erythromycin).

Q: First-pass metabolism is a significant problem for drugs administered via which route?

Oral route (directly into stomach). **Explanation:** **1. Why the Oral Route is Correct:** The **Oral route** is the most common route associated with significant **First-pass metabolism** (Presystemic metabolism). When a drug is swallowed, it is absorbed from the gastrointestinal tract into the **portal venous system**. Before reaching the systemic circulation, the drug must pass through the **liver**, which is the primary site for drug metabolism. If the liver has a high extraction ratio for a specific drug, a large fraction of the dose is inactivated before it can reach its target site, significantly reducing its **bioavailability**. **2. Analysis of Incorrect Options:** * **Sublingual route:** Drugs absorbed through the buccal mucosa drain directly into the superior vena cava, bypassing the portal circulation and the liver. This is why Nitroglycerin is given sublingually for rapid action. * **Rectal route:** The rectal venous drainage is divided. The lower part bypasses the liver, while the upper part enters the portal system. Thus, it only partially avoids first-pass metabolism (roughly 50%). * **Intramuscular route:** This is a parenteral route where the drug is absorbed directly into the systemic capillaries, completely bypassing the gastrointestinal tract and the first pass through the liver. **3. NEET-PG High-Yield Pearls:** * **Bioavailability (F):** For intravenous (IV) administration, F = 100%. For oral drugs with high first-pass metabolism (e.g., Propranolol, Lidocaine, Morphine, Nitroglycerin), F is significantly low. * **Lidocaine:** It has such high first-pass metabolism that it is practically ineffective when given orally; hence, it is used parenterally as an anti-arrhythmic. * **Propranolol:** Shows significant individual variation in oral bioavailability due to first-pass effects, requiring much higher oral doses compared to IV doses.

Q: All the following drugs act by intracellular receptors except?

Insulin. ### Explanation The correct answer is **Insulin**. **Mechanism of Action:** Receptors are broadly classified into two types based on the chemical nature of the ligand: **Cell Surface Receptors** (for water-soluble ligands) and **Intracellular Receptors** (for lipid-soluble ligands). * **Insulin** is a peptide hormone. Because it is large and hydrophilic, it cannot cross the lipid bilayer of the cell membrane. It acts via a **Cell Surface Receptor**, specifically a **Receptor Tyrosine Kinase (RTK)** [1]. Binding triggers autophosphorylation of the receptor, leading to downstream signaling (MAP kinase and PI3K pathways) [1]. **Analysis of Incorrect Options:** * **Thyroid Hormones (T3, T4):** These are unique because, despite being amino acid derivatives, they are lipophilic. They act on **Intranuclear receptors** to alter gene transcription. * **Vitamin D:** As a fat-soluble vitamin, it functions similarly to steroid hormones. It binds to the **Vitamin D Receptor (VDR)** located in the nucleus. * **Steroids:** Glucocorticoids, mineralocorticoids, and sex hormones are lipophilic. They cross the cell membrane to bind to **Cytoplasmic or Nuclear receptors**, forming a complex that acts as a transcription factor. **NEET-PG High-Yield Pearls:** 1. **Mnemonic for Intracellular Receptors:** **"VET TV"** (Vitamin D, Estrogen, Testosterone, Thyroid hormone, Vitamin A/Retinoic acid). 2. **Cytoplasmic vs. Nuclear:** While most steroids bind in the cytoplasm and then translocate, **Thyroid hormones and Estrogen** receptors are primarily located directly inside the **nucleus**. 3. **Speed of Action:** Hormones acting on intracellular receptors have a **slow onset** (hours to days) because they require protein synthesis, whereas surface receptors (like Insulin or Epinephrine) produce **rapid** effects.

Q: All of the following drugs are metabolized by acetylation, except?

Ketoconazole. **Explanation:** The question tests your knowledge of **Phase II metabolic reactions**, specifically **Acetylation**. This pathway is catalyzed by the enzyme *N-acetyltransferase* (NAT) in the liver. **Why Ketoconazole is the correct answer:** Ketoconazole is an imidazole antifungal that is primarily metabolized in the liver via **Oxidation** (Phase I reaction) through the **CYP3A4** enzyme system. It does not undergo acetylation. Notably, Ketoconazole is a potent inhibitor of CYP3A4, leading to numerous drug-drug interactions. **Analysis of Incorrect Options (Drugs that undergo Acetylation):** A classic mnemonic to remember drugs metabolized by acetylation is **"SHIP"**: * **S – Sulfonamides:** Used in various bacterial infections; their acetylated metabolites can sometimes cause crystalluria. * **H – Hydralazine:** An antihypertensive used in pregnancy-induced hypertension and heart failure. * **I – Isoniazid (INH):** A primary anti-tubercular drug. * **P – Procainamide:** A Class 1A antiarrhythmic. **High-Yield Clinical Pearls for NEET-PG:** 1. **Genetic Polymorphism:** Acetylation shows bimodal distribution in the population. Individuals are classified as **Fast Acetylators** or **Slow Acetylators**. 2. **Slow Acetylators:** These individuals are at a higher risk of drug-induced toxicity. Specifically, they are prone to **Drug-Induced Lupus Erythematosus (DILE)** when taking Hydralazine, Procainamide, or Isoniazid. 3. **Isoniazid Toxicity:** In slow acetylators, INH can cause peripheral neuropathy (due to Vitamin B6 deficiency), whereas fast acetylators may be more prone to INH-induced hepatotoxicity due to rapid conversion to acetylhydrazine.

Q: Which receptors on the cell membrane activate an ion channel after binding with agonists?

Nicotinic cholinergic. **Explanation:** The question tests the classification of cell surface receptors based on their signaling mechanisms. Receptors are broadly divided into **Ionotropic** (ligand-gated ion channels) and **Metabotropic** (G-protein coupled receptors). **1. Why Nicotinic Cholinergic is Correct:** Nicotinic receptors (both $N_m$ and $N_n$ subtypes) are classic examples of **ionotropic receptors**. Upon binding with an agonist (Acetylcholine), the receptor undergoes a conformational change that directly opens an integral ion channel. This allows the rapid influx of $Na^+$ (and efflux of $K^+$), leading to immediate membrane depolarization. This rapid action is essential for neuromuscular transmission and autonomic ganglionic signaling. **2. Why the other options are Incorrect:** * **Muscarinic Cholinergic (B):** These are **G-protein coupled receptors (GPCRs)**. They act through second messengers like $IP_3/DAG$ ($M_1, M_3$) or by inhibiting Adenylyl Cyclase ($M_2$). They do not contain an intrinsic ion channel. * **Opioid Mu Receptors (C):** These are **$G_i/G_o$ protein-coupled receptors**. They work by inhibiting adenylyl cyclase and indirectly modulating potassium and calcium channels via G-protein subunits, rather than being the channel themselves. * **GABA B Receptors (D):** Unlike GABA A (which is ionotropic/chloride channel), **GABA B is metabotropic (GPCR)**. It acts via G-proteins to increase $K^+$ conductance or decrease $Ca^{2+}$ influx. **High-Yield Clinical Pearls for NEET-PG:** * **Ionotropic Receptors (Fast):** Nicotinic (ACh), GABA A, Glycine, 5-HT3, and Glutamate (NMDA/AMPA) receptors. * **Metabotropic Receptors (Slow):** All Muscarinic, all Adrenergic, GABA B, and most Serotonin receptors (except 5-HT3). * **Exam Tip:** If a receptor's action results in "milli-second" speed responses, it is almost always an ionotropic receptor.

Q: Which of the following statements is true about steady state?

Rate of administration is equal to rate of elimination.. ### Explanation **1. Why Option A is Correct:** Steady state (Css) is a pharmacokinetic condition where the **rate of drug administration (input) equals the rate of drug elimination (output)**. At this point, the total amount of drug in the body remains constant, and the plasma concentration fluctuates within a stable range. Mathematically, it is represented as: *Rate of Infusion ($R_0$) = Clearance ($CL$) × Steady State Concentration ($C_{ss}$)*. **2. Analysis of Incorrect Options:** * **Option B:** This is incorrect because the time taken to reach steady state depends **solely on the half-life ($t_{1/2}$)** of the drug. It is independent of the dose or frequency of administration. * **Option C:** This is incorrect because the **magnitude** (level) of the plasma concentration at steady state is directly proportional to the dose rate. While the *time* to reach it is constant, a higher dose results in a higher steady-state concentration. * **Option D:** This is incorrect. A longer dosing interval allows more time for the drug to be eliminated between doses, leading to a **greater** fluctuation (wider gap) between peak ($C_{max}$) and trough ($C_{min}$) levels. **3. High-Yield Clinical Pearls for NEET-PG:** * **Rule of 4-5:** It takes approximately **4 to 5 half-lives** to reach steady state (94% at 4 $t_{1/2}$; 97% at 5 $t_{1/2}$). * **Loading Dose:** If clinical urgency requires reaching steady state immediately, a **Loading Dose** is given. However, even with a loading dose, the "true" steady state of the body is only maintained after 4-5 half-lives. * **Elimination:** Similarly, it takes 4-5 half-lives for a drug to be completely eliminated from the body after stopping the infusion.

Question 1

Which of the following statements about plasma protein binding is FALSE?

Accepted Answer

Higher plasma protein binding leads to increased storage in the liver.

Answer

Acidic drugs generally bind to plasma albumin, and basic drugs bind to alpha-1-acid glycoprotein.

Answer

Plasma protein binding influences the volume of distribution.

Answer

Higher plasma protein binding results in decreased penetration across vascular membranes.

Question 2

Nitroglycerin is effective as sublingual medication because it is:

Accepted Answer

Nonionic and highly lipid soluble

Answer

Ionic and lipid soluble

Answer

Ionic and less lipid soluble

Answer

Nonionic and less lipid soluble

Question 3

Which of the following is the fastest acting receptor?

Accepted Answer

GABAa

Answer

Beta1

Answer

M2

Answer

Estrogen receptor

Question 4

A 20-year-old patient weighing 60 kg needs an antiepileptic drug (available as 200 mg and 400 mg tablets) for generalized tonic-clonic seizures. The pharmacokinetic parameters and therapeutic plasma concentration of the selected drug are: Target steady-state plasma concentration (Cpss) – 6 mg/L, Oral bioavailability (F) – 70%, Volume of distribution (V) – 1.4 L/kg, Clearance (CL) – 80 ml/hr/kg, Plasma half-life (t½) – 15 hours. What should be the loading dose and the daily maintenance dose of the drug for this patient?

Accepted Answer

720 mg and 984 mg respectively

Answer

984 mg and 720 mg respectively

Answer

450 mg and 720 mg respectively

Answer

884 mg and 984 mg respectively

Question 5

A young male presents with severe asthma. The pharmacokinetics of theophylline include the following parameters: Vd = 35 L; CL = 48 mL/min; half-life = 8 hours. If an intravenous infusion of theophylline is started at a rate of 0.48 mg/min, how long will it take to reach 93.75% of the steady state concentration?

Accepted Answer

Approximately 32 hours

Answer

Approximately 48 minutes

Answer

Approximately 5.8 hours

Answer

Approximately 8 hours

Question 6

First-pass metabolism is a significant problem for drugs administered via which route?

Accepted Answer

Oral route (directly into stomach)

Answer

Sublingual route

Answer

Rectal route

Answer

Intramuscular route

Question 7

All the following drugs act by intracellular receptors except?

Accepted Answer

Insulin

Answer

Thyroid hormones

Answer

Vitamin D

Answer

Steroids

Question 8

All of the following drugs are metabolized by acetylation, except?

Accepted Answer

Ketoconazole

Answer

Isoniazid (INH)

Answer

Sulfonamides

Answer

Hydralazine

Question 9

Which receptors on the cell membrane activate an ion channel after binding with agonists?

Accepted Answer

Nicotinic cholinergic

Answer

Muscarinic cholinergic

Answer

Opioid mu receptors

Answer

GABA B receptors

Question 10

Which of the following statements is true about steady state?

Accepted Answer

Rate of administration is equal to rate of elimination.

Answer

It does not depend upon half-life.

Answer

Plasma concentration achieved is independent of dose rate.

Answer

The longer the dosing interval, the lesser the difference between peak and trough values.

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?